Condition
Endocrine Cancer
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 4 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
4 shownSymptom Management for YA Cancer SurvivorsNCT04035447 · 2020-01-22
COMPLETEDFeasibility of Activity Monitoring in Patients With Cancer: Physical Activity Monitoring in Cancer Patients (PAMCaP)NCT02583815 · 2015-08-01
COMPLETEDStudy of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum CalciumNCT00896454 · 2009-11-16
COMPLETEDB-Receptor Signaling in CardiomyopathyNCT01135849 · 2008-11-01
COMPLETEDCommon interventions
Leading sponsors
Trial status mix
COMPLETED4
Phase mix
NA1
PHASE21
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.